Thus, MYH11 rare variants may trigger excessive SMC IGF-1 production and be the source of SMC-to-cardiomyocyte signaling to drive cardiac hypertrophy and failure in Myh11E1892D/E1892D mice after TAC. Here, MYH11 is linked to cardiac hypertrophy.